Clinical Trial

Lead Exposure and Multiple Sclerosis

Name: Lead Exposure and Multiple Sclerosis — clinical trial record (NCT07423312)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

1. To evaluate the effect of lead level on the pathogenesis of multiple sclerosis 2. Measure lead in blood sample of study groups 3. Estimate the expression level of DNA methyltransferase. 4. Evaluate oxidative stress markers, like MDA/8-OHdG 5. Measureδ-aminolevulinic acid 6. Correlate the clinical data of patients with biochemical markers

Trial Details

NCT Number	NCT07423312
Lead Sponsor	Assiut University
Conditions	Multiple Sclerosis
Enrollment	140 participants
Start Date	2026-12-30
Primary Completion	2028-12-30 (estimated)
Study Completion	2029-05-05 (estimated)
Updated on ClinicalTrials.gov	2026-02-20